NYSE American - Nasdaq Real Time Price USD

Milestone Scientific Inc. (MLSS)

Compare
0.9320 +0.0157 (+1.71%)
As of 12:02 PM EDT. Market Open.
Loading Chart for MLSS
DELL
  • Previous Close 0.9163
  • Open 0.9200
  • Bid 0.9200 x 1800
  • Ask 0.9399 x 900
  • Day's Range 0.9200 - 0.9399
  • 52 Week Range 0.5200 - 1.1000
  • Volume 9,609
  • Avg. Volume 137,175
  • Market Cap (intraday) 72.032M
  • Beta (5Y Monthly) 1.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Nov 13, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

www.milestonescientific.com

17

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MLSS

View More

Performance Overview: MLSS

Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MLSS
35.07%
S&P 500
20.19%

1-Year Return

MLSS
5.91%
S&P 500
35.55%

3-Year Return

MLSS
51.71%
S&P 500
31.58%

5-Year Return

MLSS
16.50%
S&P 500
96.96%

Compare To: MLSS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MLSS

View More

Valuation Measures

Annual
As of 10/3/2024
  • Market Cap

    70.82M

  • Enterprise Value

    65.41M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.37

  • Price/Book (mrq)

    8.90

  • Enterprise Value/Revenue

    7.77

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -54.88%

  • Return on Assets (ttm)

    -36.34%

  • Return on Equity (ttm)

    -59.40%

  • Revenue (ttm)

    8.42M

  • Net Income Avi to Common (ttm)

    -4.62M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.75M

  • Total Debt/Equity (mrq)

    4.28%

  • Levered Free Cash Flow (ttm)

    -2.74M

Research Analysis: MLSS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.85M
Earnings 223.64k
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: MLSS

People Also Watch